Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?

Genes, Brain, and Behavior
D MuyllaertF Van Leuven

Abstract

Phosphorylation is the most common post-translational modification of cellular proteins, essential for most physiological functions. Deregulation of phosphorylation has been invoked in disease mechanisms, and the case of Alzheimer's disease (AD) is no exception: both in the amyloid pathology and in the tauopathy are kinases deeply implicated. The glycogen synthase kinase-3 (GSK-3) isozymes participate in diverse cellular processes and important signalling pathways and have been implicitly linked to diverse medical problems, i.e. from diabetes and cancer to mood disorders and schizophrenia, and in the neurodegeneration of AD. Here, we review specific aspects of GSK-3 isozymes in the framework of recent data that we obtained in novel transgenic mouse models that robustly recapitulate the pathology and mechanistical problems of AD.

References

Sep 24, 1993·Annals of the New York Academy of Sciences·E M MandelkowE Mandelkow
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·J D YorkP W Majerus
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A TakashimaK Imahori
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·P S Klein, D A Melton
Oct 6, 1997·The Journal of Biological Chemistry·M HongV M Lee
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·A TakashimaB Wolozin
Aug 18, 1999·Journal of Chemical Neuroanatomy·K Leroy, J P Brion
Sep 28, 1999·Journal of Neuropathology and Experimental Neurology·J J PeiR F Cowburn
Mar 23, 2000·Progress in Neurobiology·F van Leuven
Sep 1, 2000·Brain Research. Brain Research Reviews·L BuéeP R Hof
Feb 13, 2001·Biochemical and Biophysical Research Communications·W J Ryves, A J Harwood
Jun 28, 2001·Nature Structural Biology·E ter HaarJ Jain
Aug 31, 2001·Progress in Neurobiology·C A Grimes, R S Jope
Oct 5, 2001·Nature Reviews. Molecular Cell Biology·P Cohen, S Frame
Nov 14, 2002·Neuromolecular Medicine·Dick TerwelFred Van Leuven
Mar 5, 2003·Journal of Cell Science·Bradley W Doble, James R Woodgett
May 23, 2003·Nature·Christopher J PhielPeter S Klein
Apr 23, 2004·Trends in Biochemical Sciences·Richard S Jope, Gail V W Johnson
May 15, 2004·Molecular and Cellular Biology·Deppie PapadopoulouMarc Bourouis
Nov 13, 2004·Journal of Cell Science·Gail V W Johnson, William H Stoothoff
Jan 13, 2005·Acta Neuropathologica·Khalid Iqbal, Inge Grundke-Iqbal
Jan 18, 2005·Cell·Takeshi YoshimuraKozo Kaibuchi
Mar 15, 2005·Alzheimer Disease and Associated Disorders·Nick DunnMark Mullee

❮ Previous
Next ❯

Citations

Sep 26, 2008·Journal of Medicinal Chemistry·Konstantina VougogiannopoulouLaurent Meijer
Oct 8, 2008·Molecular and Cellular Biology·Amy Jo Galliher-BeckleyJohn Anthony Cidlowski
Jun 22, 2012·International Journal of Alzheimer's Disease·Natalia Crespo-BielFred Van Leuven
Apr 29, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Orestes V ForlenzaWagner F Gattaz
Nov 11, 2011·International Journal of Environmental Research and Public Health·Glen E Kisby, Peter S Spencer
Sep 24, 2010·International Journal of Alzheimer's Disease·Tomasz JaworskiFred Van Leuven
Jun 2, 2011·International Journal of Alzheimer's Disease·Miguel Medina, Francisco Wandosell
Jun 2, 2011·International Journal of Alzheimer's Disease·Jari KoistinahoGundars Goldsteins
Feb 16, 2010·Aging Clinical and Experimental Research·Francesco PanzaAlberto Pilotto
Oct 29, 2008·FEBS Letters·Félix Hernández, Jesús Avila
Mar 5, 2016·Journal of Pharmaceutical and Biomedical Analysis·Annalisa D'UrzoVincenza Andrisano
Feb 3, 2016·Journal of Alzheimer's Disease : JAD·Chunxia HuangGordon Tin-Chun Wong
Apr 25, 2009·IUBMB Life·Karl Peter Giese
Nov 6, 2009·CNS Neuroscience & Therapeutics·Antoni CaminsMercé Pallás
Jan 16, 2013·Depression Research and Treatment·Yasuko KitagishiSatoru Matsuda
Oct 9, 2013·Expert Opinion on Therapeutic Targets·Miguel Medina, Jesús Avila
Mar 15, 2015·Experimental & Molecular Medicine·Bhumsoo Kim, Eva L Feldman
May 29, 2016·Physiology & Behavior·Vanita RaniJitender Bariwal
Jan 17, 2012·Trends in Endocrinology and Metabolism : TEM·Bhumsoo Kim, Eva L Feldman
Nov 10, 2016·Expert Opinion on Therapeutic Patents·Valle Palomo, Ana Martinez
Mar 8, 2017·Journal of Pharmaceutical and Biomedical Analysis·Angela De SimoneVincenza Andrisano
Feb 23, 2017·Journal of Alzheimer's Disease : JAD·Francis T HaneZoya Leonenko

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.